Back
Verve Therapeutics Vs. 10x Genomics Industry Stock Comparison
Sell
36
VERV
Verve Therapeutics
Last Price:
5.60
Seasonality Move:
-34.1%
Sell
33
TXG
10x Genomics
Last Price:
21.55
Seasonality Move:
3.95%
Sell
36
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $5.60. The Score for VERV is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
10x Genomics (TXG)
is a Sell
Is 10x Genomics a Buy, Sell or Hold?
- The current 10x Genomics [TXG] share price is $21.55. The Score for TXG is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- TXG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $5.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
TXG Stock Price Chart
What is 10x Genomics's stock price today?
-
The 10x Genomics share price today is $21.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TXG is experiencing selling pressure, which indicates risk of future bearish movement.
VERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 48.86 | Sell |
Chaikin Money Flow: | 756028 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.75 - 6.03) | Buy |
Bollinger Bands (100): | (5.07 - 6.69) | Sell |
TXG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.69 | Buy |
Relative Strength Index (14 RSI): | 49.08 | Sell |
Chaikin Money Flow: | -840207 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.84 - 23.2) | Buy |
Bollinger Bands (100): | (18.84 - 25.62) | Sell |
VERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.94 | Sell |
20-day SMA: | 5.26 | Buy |
50-day SMA: | 5.93 | Sell |
200-day SMA: | 9.27 | Sell |
8-day EMA: | 5.76 | Sell |
20-day EMA: | 5.65 | Sell |
50-day EMA: | 5.86 | Sell |
200-day EMA: | 8.84 | Sell |
TXG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.71 | Sell |
20-day SMA: | 22.2 | Sell |
50-day SMA: | 20.14 | Buy |
200-day SMA: | 33.42 | Sell |
8-day EMA: | 22.57 | Sell |
20-day EMA: | 22.05 | Sell |
50-day EMA: | 21.61 | Sell |
200-day EMA: | 30.23 | Sell |
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
10x Genomics Earnings Growth & TXG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.28 per share, an increase this year of $0.17 per share, and an increase next year of $0.30 per share.
Verve Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
10x Genomics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |